Laboratoires Euromedis Société anonyme (FRA:61R)
Germany · Delayed Price · Currency is EUR 3.890
+0.060 (1.57%)
Last updated: Nov 28, 2025, 8:11 AM CET
FRA:61R Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Operating Revenue | 38.4 | 36.22 | 34.04 | 54.18 | 111.9 | 193.41 | Upgrade |
Other Revenue | 0.2 | 0.2 | 0.03 | 0 | - | -0.01 | Upgrade |
| 38.59 | 36.41 | 34.07 | 54.18 | 111.9 | 193.4 | Upgrade | |
Revenue Growth (YoY) | 39.61% | 6.88% | -37.13% | -51.58% | -42.14% | 150.73% | Upgrade |
Cost of Revenue | 37.11 | 34.29 | 33.86 | 35.44 | 78.41 | 129.26 | Upgrade |
Gross Profit | 1.48 | 2.12 | 0.21 | 18.75 | 33.49 | 64.14 | Upgrade |
Selling, General & Admin | 1.85 | 3.1 | 4.21 | 25.35 | 27.23 | 28.03 | Upgrade |
Other Operating Expenses | -2.17 | -1.6 | 1.35 | -6.66 | -4.96 | -0.46 | Upgrade |
Operating Expenses | 0.58 | 1.72 | 5.77 | 23.88 | 29.3 | 34.17 | Upgrade |
Operating Income | 0.9 | 0.4 | -5.56 | -5.14 | 4.19 | 29.97 | Upgrade |
Interest Expense | -0.55 | -0.5 | -0.36 | -0.37 | -0.35 | -0.46 | Upgrade |
Interest & Investment Income | 0.62 | 0.62 | 27.78 | - | - | - | Upgrade |
Earnings From Equity Investments | - | - | - | 0.02 | 0.02 | -0.12 | Upgrade |
Currency Exchange Gain (Loss) | -0.05 | 0.03 | -0.02 | -0.03 | -0.08 | 0.58 | Upgrade |
Other Non Operating Income (Expenses) | 0.15 | -0.11 | -0.01 | 0.25 | 0.01 | -0.39 | Upgrade |
EBT Excluding Unusual Items | 1.07 | 0.43 | 21.83 | -5.27 | 3.79 | 29.58 | Upgrade |
Impairment of Goodwill | - | - | - | -0.09 | - | -0.72 | Upgrade |
Asset Writedown | -6 | -6 | 12.3 | -0.43 | -1.13 | -4.39 | Upgrade |
Other Unusual Items | -0.55 | -0.55 | -20.75 | -0.19 | -0.15 | 3.92 | Upgrade |
Pretax Income | -5.48 | -6.11 | 13.38 | -5.98 | 2.51 | 28.39 | Upgrade |
Income Tax Expense | 0 | -0 | 0.27 | -0.04 | 0.21 | 5.53 | Upgrade |
Earnings From Continuing Operations | -5.48 | -6.11 | 13.11 | -5.94 | 2.3 | 22.87 | Upgrade |
Minority Interest in Earnings | - | - | - | 0.01 | -0.05 | -0.2 | Upgrade |
Net Income | -5.48 | -6.11 | 13.11 | -5.93 | 2.26 | 22.66 | Upgrade |
Net Income to Common | -5.48 | -6.11 | 13.11 | -5.93 | 2.26 | 22.66 | Upgrade |
Net Income Growth | - | - | - | - | -90.05% | - | Upgrade |
Shares Outstanding (Basic) | - | 3 | 3 | 3 | 3 | 3 | Upgrade |
Shares Outstanding (Diluted) | - | 3 | 3 | 3 | 4 | 4 | Upgrade |
Shares Change (YoY) | - | 0.21% | -4.50% | -15.98% | - | 19.87% | Upgrade |
EPS (Basic) | - | -2.12 | 4.56 | -1.97 | 0.75 | 7.53 | Upgrade |
EPS (Diluted) | - | -2.12 | 4.56 | -1.97 | 0.63 | 6.33 | Upgrade |
EPS Growth | - | - | - | - | -90.05% | - | Upgrade |
Free Cash Flow | - | - | - | -2.08 | 17.41 | 12.84 | Upgrade |
Free Cash Flow Per Share | - | - | - | -0.69 | 4.86 | 3.58 | Upgrade |
Gross Margin | 3.84% | 5.83% | 0.62% | 34.60% | 29.93% | 33.17% | Upgrade |
Operating Margin | 2.34% | 1.09% | -16.31% | -9.48% | 3.75% | 15.50% | Upgrade |
Profit Margin | -14.19% | -16.78% | 38.48% | -10.95% | 2.02% | 11.72% | Upgrade |
Free Cash Flow Margin | - | - | - | -3.84% | 15.56% | 6.64% | Upgrade |
EBITDA | 1.8 | 0.62 | -4.44 | -4.01 | 5.2 | 34.41 | Upgrade |
EBITDA Margin | 4.67% | 1.70% | -13.02% | -7.41% | 4.64% | 17.79% | Upgrade |
D&A For EBITDA | 0.9 | 0.22 | 1.12 | 1.12 | 1 | 4.44 | Upgrade |
EBIT | 0.9 | 0.4 | -5.56 | -5.14 | 4.19 | 29.97 | Upgrade |
EBIT Margin | 2.34% | 1.09% | -16.31% | -9.48% | 3.75% | 15.50% | Upgrade |
Effective Tax Rate | - | - | 2.01% | - | 8.35% | 19.46% | Upgrade |
Revenue as Reported | 43.01 | 40.28 | 37.43 | 61.35 | 117.61 | 195.62 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.